EQL Pharma AB (OSTO:EQL) Cyclically Adjusted Book per Share: kr4.75 (As of Mar. 2026)


OSTO:EQL EQL Pharma AB OSTO:EQL
42 GF Score
Price kr23.15
! 4 Warning Signs
View Full Analysis

What is EQL Pharma AB Cyclically Adjusted Book per Share?

EQL Pharma AB OSTO:EQL -2.32% 42 Cyclically Adjusted Book per Share is kr4.75 as of Mar. 2026. GuruFocus rates OSTO:EQL with a GF Score™ of 42/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

EQL Pharma AB's adjusted book value per share for the three months ended in Mar. 2026 was kr9.044. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr4.75 for the trailing ten years ended in Mar. 2026.

During the past 12 months, EQL Pharma AB's average Cyclically Adjusted Book Growth Rate was 19.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 18.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of EQL Pharma AB was 18.80% per year. The lowest was 18.80% per year. And the median was 18.80% per year.

As of today (2026-07-03), EQL Pharma AB's current stock price is kr23.15. EQL Pharma AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr4.75. EQL Pharma AB's Cyclically Adjusted PB Ratio of today is 4.87.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of EQL Pharma AB was 23.30. The lowest was 4.97. And the median was 16.66.


EQL Pharma AB  (OSTO:EQL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

EQL Pharma AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=23.15/4.75
=4.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of EQL Pharma AB was 23.30. The lowest was 4.97. And the median was 16.66.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


EQL Pharma AB Cyclically Adjusted Book per Share Related Terms


EQL Pharma AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for EQL Pharma AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EQL Pharma AB Cyclically Adjusted Book per Share Chart

EQL Pharma AB Annual Data
Trend Dec16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 2.83 3.30 3.97 4.75

EQL Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.97 4.18 4.38 4.59 4.75

OSTO:EQL vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EQL Pharma AB Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's Cyclically Adjusted PB Ratio falls into.


OSTO:EQL
42GF Score
EQL Pharma AB OSTO:EQL
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EQL Pharma AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, EQL Pharma AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=9.044/133.5600*133.5600
=9.044

Current CPI (Mar. 2026) = 133.5600.

EQL Pharma AB Quarterly Data

Book Value per Share CPI Adj_Book
201603 1.998 100.751 2.649
201606 2.002 101.019 2.647
201609 2.003 101.138 2.645
201612 2.242 102.022 2.935
201703 2.157 102.022 2.824
201706 2.150 102.752 2.795
201709 2.175 103.279 2.813
201803 2.134 103.962 2.742
201806 2.139 104.875 2.724
201809 2.185 105.679 2.761
201812 2.726 105.912 3.438
201903 2.691 105.886 3.394
201906 2.691 106.742 3.367
201909 2.728 107.214 3.398
201912 2.778 107.766 3.443
202003 2.784 106.563 3.489
202006 3.170 107.498 3.939
202009 3.281 107.635 4.071
202012 3.356 108.296 4.139
202103 3.139 108.360 3.869
202106 3.225 108.928 3.954
202109 3.420 110.338 4.140
202112 4.030 112.486 4.785
202203 4.254 114.825 4.948
202206 4.508 118.384 5.086
202209 4.765 122.296 5.204
202212 5.183 126.365 5.478
202303 5.325 127.042 5.598
202306 5.560 129.407 5.738
202309 5.730 130.224 5.877
202312 5.953 131.912 6.027
202403 6.115 132.205 6.178
202406 6.473 132.716 6.514
202409 6.809 132.304 6.874
202412 7.155 132.987 7.186
202503 7.605 132.825 7.647
202506 7.943 133.699 7.935
202509 8.804 133.480 8.809
202512 9.136 133.390 9.148
202603 9.044 133.560 9.044

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr4.75 mean?
EQL Pharma AB (OSTO:EQL) has a Cyclically Adjusted Book per Share of kr4.75 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on EQL Pharma AB and its competitors.
Is EQL Pharma AB's Cyclically Adjusted Book per Share too high?
EQL Pharma AB's current Cyclically Adjusted Book per Share is kr4.75. Overall, EQL Pharma AB has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does EQL Pharma AB's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
EQL Pharma AB's Cyclically Adjusted Book per Share of kr4.75 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on EQL Pharma AB and its competitors. EQL Pharma AB's current Cyclically Adjusted Book per Share is kr4.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EQL Pharma AB stock overvalued right now?
EQL Pharma AB (OSTO:EQL) has a current Cyclically Adjusted Book per Share of kr4.75. The current Cyclically Adjusted Book per Share is kr4.75. EQL Pharma AB's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For EQL Pharma AB (OSTO:EQL), the current Cyclically Adjusted Book per Share is kr4.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EQL Pharma AB Business Description

Other Exchanges 7JK:Germany
Address Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company focused on efficiently and thoughtfully developing and marketing generic drugs. The company operates in one segment, which is medicine. Its niche generics are divided into four parts based on four sales and marketing models: Retail, Hospital, Branded, and Tests. EQL Pharma specializes in identifying, developing, and selling generics, i.e., medicines that are medically equivalent to originator medicines. The company operates in Sweden, Denmark, Norway, Finland, the rest of Europe, and outside Europe, generating the majority of its revenue from Sweden.
42GF Score

Get the complete analysis for OSTO:EQL

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr23.15
Price